Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Biomarkers ; 28(2): 238-248, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36576409

ABSTRACT

Objective: In this study, we aimed to determine the role of Psidium cattleianum extract (PCE) and compare its effects with those of metformin (Met) in an animal model with type 2 diabetes mellitus (T2DM).Methods: T2DM was induced in rats using a high-fat diet (HFD), followed by a single dose of streptozotocin (STZ). Met and PCE were administered intragastrically once a day throughout the experiment, and their effects on biochemical, inflammatory, oxidative, and histological parameters were evaluated.Results: Met and PCE prevented the increase in serum levels of glucose, total cholesterol (TC), triacylglycerol (TG), very low-density lipoprotein (VLDL) and interleukin-6 (IL-6) induced by T2DM, and restored redox homeostasis in the liver and brain. Met increased the serum levels of anti-inflammatory cytokine and interleukin-10 (IL-10). Furthermore, both treatments restored the liver and pancreas from marked cellular disorganisation, vacuolisation, and necrosis, with PCE being more effective than Met in recovering histological changes.Conclusion: PCE is a promising agent for the prevention of T2DM complications.


Subject(s)
Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Metformin , Psidium , Animals , Rats , Blood Glucose , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/pathology , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/pathology , Fruit , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Metformin/therapeutic use , Models, Animal
2.
Metab Brain Dis ; 37(3): 835-847, 2022 03.
Article in English | MEDLINE | ID: mdl-35043268

ABSTRACT

Bipolar disorder (BD) is a psychiatric disease characterized by mood episodes. Blueberry is rich in bioactive compounds and shows excellent therapeutic potential against chronic diseases. The aim of this study was to evaluate the effects of blueberry extract on behavior, energetic metabolism, Ca2+-ATPase activity, and levels of brain-derived neurotrophic factor (BDNF) in the cerebral cortex and hippocampus of rats submitted to an animal model of mania induced by ketamine. Vehicle, lithium (45 mg/kg, twice a day), or blueberry extract (200 mg/kg), was orally administered to Wistar rats for 14 days. Ketamine (25 mg/kg) or vehicle was administered intraperitoneally, once a day, between the 8th and 14th day. On the 15th day, animals received ketamine or vehicle and were subjected to the open field test. Our results demonstrated that the administration of lithium and blueberry extract prevented ketamine-induced hyperlocomotion (P < 0.01). Blueberry extract attenuated the ketamine-induced reduction in the activity of complex I in the cerebral cortex (P < 0.05). Additionally, the administration of ketamine reduced the activities of complexes I and IV (P < 0.05) and citrate synthase in the hippocampus (P < 0.01). However, blueberry extract attenuated the inhibition in the activity of complex IV (P < 0.01). Furthermore, ketamine reduced the Ca2+-ATPase activity in the cerebral cortex and hippocampus (P < 0.05); however, blueberry extract prevented the change in the cerebral cortex (P < 0.05). There were no significant alterations in the levels of BDNF (P > 0.05). In conclusion, this suggested that the blueberry extract can serve as a potential therapeutic strategy for studies searching for novel therapeutic alternatives for BD patients.


Subject(s)
Blueberry Plants , Ketamine , Adenosine Triphosphatases/metabolism , Animals , Behavior, Animal , Blueberry Plants/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Cerebral Cortex/metabolism , Disease Models, Animal , Hippocampus/metabolism , Ketamine/pharmacology , Mania , Plant Extracts/metabolism , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Wistar
3.
Arch Physiol Biochem ; 128(4): 993-1000, 2022 Aug.
Article in English | MEDLINE | ID: mdl-32212985

ABSTRACT

In this study, we evaluated the effects of native fruit extracts on inflammatory and thromboregulatory parameters in animal model of metabolic syndrome (MetS) induced by highly palatable diet (HPD). Rats were divided into 4 experimental groups: standard chow, HPD, HPD and Psidium cattleianum extract, and HPD and Eugenia uniflora extract. HPD increased serum interleukin-6 (IL-6) levels. On the other hand, this change was prevented by extracts. HPD decreased NTPDase activity in lymphocytes and platelets and 5'-nucleotidase in platelets. Treatment with extracts prevented these changes. An increase in adenosine deaminase (ADA) activity was prevented by E. uniflora in lymphocytes and serum of rats. Fruit extracts prevented the increase in the activity of acetylcholinesterase (AChE) in lymphocytes and butyrylcholinesterase (BuChE) in serum induced by the HPD. Brazilian native fruit extracts have anti-inflammatory and antithrombotic effects, demonstrating therapeutic potential in the prevention of complications associated with MetS.


Subject(s)
Metabolic Syndrome , Acetylcholinesterase/metabolism , Animals , Blood Cells/metabolism , Brazil , Butyrylcholinesterase , Cholinergic Agents/therapeutic use , Fruit , Metabolic Syndrome/metabolism , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Rats , Rats, Wistar
4.
Neurochem Res ; 46(5): 1129-1140, 2021 May.
Article in English | MEDLINE | ID: mdl-33547616

ABSTRACT

Neuroinflammation is an event that occurs in several pathologies of brain. Rubus sp. (blackberry) is a powerful antioxidant fruit, and its extract has neuroprotective activity. The aim of this study was to investigate the blackberry extract properties on lipopolysaccharide (LPS)-induced neuroinflammation, in relation to oxidative parameters and acetylcholinesterase activity in the brain structures of mice. We also investigated interleukin-10 levels in serum. Mice were submitted to Rubus sp. extract treatment once daily for 14 days. On the fifteenth day, LPS was injected in a single dose. LPS induced oxidative brain damage and the blackberry extract demonstrated preventive effects in LPS-challenged mice. LPS administration increased reactive oxygen species levels in the cerebral cortex and striatum, as well as lipid peroxidation in the cerebral cortex. However, the blackberry extract prevented all these parameters. Furthermore, LPS decreased thiol content in the striatum and hippocampus, while a neuroprotective effect of blackberry extract treatment was observed in relation to this parameter. The blackberry extract also prevented a decrease in catalase activity in all the brain structures and of superoxide dismutase in the striatum. An increase in acetylcholinesterase activity was detected in the cerebral cortex in the LPS group, but this activity was decreased in the Rubus sp. extract group. Serum IL-10 levels were reduced by LPS, and the extract was not able to prevent this change. Finally, we observed an antioxidant effect of blackberry extract in LPS-challenged mice suggesting that this anthocyanin-rich extract could be considered as a potential nutritional therapeutic agent for preventive damage associated with neuroinflammation.


Subject(s)
Antioxidants/therapeutic use , Inflammation/drug therapy , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Plant Extracts/therapeutic use , Acetylcholinesterase/metabolism , Animals , Brain/drug effects , Brain/metabolism , Fruit/chemistry , GPI-Linked Proteins/metabolism , Inflammation/metabolism , Interleukin-10/metabolism , Lipopolysaccharides/pharmacology , Male , Mice , Rubus/chemistry
5.
J Food Biochem ; : e13442, 2020 Aug 17.
Article in English | MEDLINE | ID: mdl-32803896

ABSTRACT

The aim of the current study was to evaluate the effect of chronic administration of Eugenia uniflora fruit extract on behavioral parameters, oxidative stress markers, and acetylcholinesterase activity in an animal model of depression, which was induced by chronic unpredictable stress (CUS). Mice were divided into six groups as follows: control/vehicle (water), control/fluoxetine (20 mg/kg), control/extract (200 mg/kg), CUS/vehicle, CUS/fluoxetine (20 mg/kg), and CUS/extract (200 mg/kg). Animals of the CUS group were exposed to a series of stressors for a period of 21 days. Vehicle, fluoxetine, and hydroalcoholic extract were administered daily by gavage. Results showed that E. uniflora treatment: (a) prevented the depressant-like effect induced by CUS; (b) regulated the activity of acetylcholinesterase; (c) reduced oxidative damage to lipids and reactive oxygen species production, in the prefrontal cortex and hippocampus; and (d) prevented the reduction of glutathione peroxidase in the hippocampus of animals subjected to CUS protocol. Taken together, our findings suggested that E. uniflora extract exerts a neuroprotective effect by preventing oxidative damage and decreasing CUS-induced acetylcholinesterase activity, thus, ameliorating depressive-type behavior. PRACTICAL APPLICATIONS: E. uniflora fruit extract revealed an antidepressant-like effect and prevented the oxidative damage as well as cholinergic alterations caused by chronic stress in mice. Therefore, we believe that the results obtained in this study can be used to develop an alternative therapy for the management of depressive disorders.

6.
Biomarkers ; 25(5): 417-424, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32519899

ABSTRACT

Aim: This study investigated the effects of polar Butia odorata fruit extract on metabolic, inflammatory, and oxidative stress parameters in rats submitted to a hyperlipidaemia condition induced by tyloxapol.Methods: Animals were divided into 3 groups: saline, saline plus tyloxapol, and B. odorata extract plus tyloxapol. Animals were treated for 15 days with a saline solution or B. odorata fruit extract and after hyperlipidaemia was induced by tyloxapol.Results: Treatment with B. odorata extract reduced serum triglyceride, total cholesterol, C-reactive protein, and adenosine deaminase and butyrylcholinesterase activities when compared to the tyloxapol group. HDL-cholesterol and paraoxonase 1 activity were higher in B. odorata extract treated animals when compared to tyloxapol-treated animals. No differences were observed in hepatic oxidative stress parameters. Phenolic compounds present in B. odorata fruit extract were identified and quantified by LC-MS/MS.Conclusion: These findings indicated that phenolic rich B. odorata extract has hypolipidemic and anti-inflammatory effects in hyperlipidemic rats.


Subject(s)
Arecaceae/chemistry , Aryldialkylphosphatase/genetics , Liver/drug effects , Oxidative Stress/drug effects , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , C-Reactive Protein/metabolism , Cholesterol, HDL/blood , Chromatography, Liquid , Fruit/chemistry , Humans , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/pharmacology , Male , Phenols/chemistry , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats , Tandem Mass Spectrometry , Triglycerides/blood
7.
Neurosci Lett ; 714: 134566, 2020 01 01.
Article in English | MEDLINE | ID: mdl-31698027

ABSTRACT

Bipolar disorder is a chronic mood disorder characterized by episodes of mania and depression. The aim of this study was to investigate the effects of blackberry extract on behavioral parameters, oxidative stress and inflammatory markers in a ketamine-induced model of mania. Animals were pretreated with extract (200 mg/kg, once a day for 14 days), lithium chloride (45 mg/kg, twice a day for 14 days), or vehicle. Between the 8th and 14th days, the animals received an injection of ketamine (25 mg/kg) or vehicle. On the 15th day, thirty minutes after ketamine administration, the animals' locomotion was assessed using open-field apparatus. After the experiments, the animals were euthanized and cerebral structures were removed for neurochemical analyses. The results showed that ketamine treatment induced hyperlocomotion and oxidative damage in the cerebral cortex, hippocampus and striatum. In contrast, pretreatment with the extract or lithium was able to prevent hyperlocomotion and oxidative damage in the cerebral cortex, hippocampus, and striatum. In addition, IL-6 and IL-10 levels were increased by ketamine, while the extract prevented these effects in the cerebral cortex. Pretreatment with the extract was also effective in decreasing IL-6 and increasing the level of IL-10 in the striatum. In summary, our findings suggest that blackberry consumption could help prevent or reduce manic episodes, since this extract have demonstrated neuroprotective properties as well as antioxidant and anti-inflammatory effects in the ketamine-induced mania model.


Subject(s)
Anthocyanins , Fruit , Mania/metabolism , Plant Extracts/pharmacology , Rubus , Animals , Antimanic Agents/pharmacology , Behavior, Animal/drug effects , Catalase/drug effects , Catalase/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cytokines/drug effects , Cytokines/metabolism , Disease Models, Animal , Excitatory Amino Acid Antagonists/toxicity , Glutathione Peroxidase/drug effects , Glutathione Peroxidase/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Ketamine/toxicity , Lithium Chloride/pharmacology , Mania/chemically induced , Mania/physiopathology , Neostriatum/drug effects , Neostriatum/metabolism , Open Field Test , Plant Extracts/chemistry , Rats , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
8.
Metab Brain Dis ; 34(2): 605-619, 2019 04.
Article in English | MEDLINE | ID: mdl-30535659

ABSTRACT

Bipolar disorder is a psychiatric disease characterized by recurrent episodes of mania and depression. Blueberries contain bioactive compounds with important pharmacological effects such as neuroprotective and antioxidant actions. The aim of this study was to investigate the effects of blueberry extract and/or lithium on oxidative stress, and acetylcholinesterase (AChE) and Na+, K+-ATPase activity in an experimental ketamine-induced model of mania. Male Wistar rats were pretreated with vehicle, blueberry extract (200 mg/kg), and/or lithium (45 mg/kg or 22.5 mg/kg twice daily) for 14 days. Between the 8th and 14th days, the animals also received an injection of ketamine (25 mg/kg) or vehicle. On the 15th day the animals received a single injection of ketamine; after 30 min, the locomotor activity was evaluated in an open field test. Ketamine administration induced an increase in locomotor activity. In the cerebral cortex, hippocampus and striatum, ketamine also induced an increase in reactive oxygen species, lipid peroxidation and nitrite levels, as well a decrease in antioxidant enzyme activity. Pretreatment with blueberry extract or lithium was able to prevent this change. Ketamine increased the AChE and Na+, K+-ATPase activity in brain structures, while the blueberry extract partially prevented these alterations. In addition, our results showed that the neuroprotective effect was not potentiated when lithium and blueberry extract treatment were given together. In conclusion, our findings suggest that blueberry extract has a neuroprotective effect against an experimental model of mania. However, more studies should be performed to evaluate its effects as an adjuvant therapy.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Blueberry Plants , Lithium/pharmacology , Animals , Antioxidants/pharmacology , Behavior, Animal/drug effects , Lipid Peroxidation/drug effects , Locomotion/drug effects , Male , Models, Theoretical , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Rats, Wistar , Thiobarbituric Acid Reactive Substances/pharmacology
9.
Metab Brain Dis ; 33(5): 1551-1562, 2018 10.
Article in English | MEDLINE | ID: mdl-29882020

ABSTRACT

In this work, we evaluated the effects of Psidium cattleianum (Red Type) (PcRT) fruit extract on metabolic, behavioral, and neurochemical parameters in rats fed with a highly palatable diet (HPD) consisted of sucrose (65% carbohydrates being 34% from condensed milk, 8% from sucrose and 23% from starch, 25% protein and 10% fat). Animals were divided into 4 groups: standard chow, standard chow + PcRT extract (200 mg/Kg/day by gavage), HPD, HPD + extract. The animals were treated for 150 days. Concerning chemical profiling, LC/PDA/MS/MS analysis revealed cyanidin-3-O-glucoside as the only anthocyanin in the PcRT extract. Our results showed that the animals exposed to HPD presented glucose intolerance, increased weight gain and visceral fat, as well as higher serum levels of glucose, triacylglycerol, total cholesterol, LDL-cholesterol and interleukin-6. These alterations were prevented by PcRT. In addition, HPD caused an increase in immobility time in a forced swimming test and the fruit extract prevented this alteration, indicating an antidepressant-like effect. PcRT treatment also prevented increased acetylcholinesterase activity in the prefrontal cortex caused by HPD consumption. Moreover, PcRT extract was able to restore Ca2+-ATPase activity in the prefrontal cortex, hippocampus, and striatum, as well as Na+,K+-ATPase activity in the prefrontal cortex and hippocampus. PcRT treatment decreased thiobarbituric acid-reactive substances, nitrite, and reactive oxygen species levels and prevented the reduction of superoxide dismutase activity in all cerebral structures of the HPD group. Additionally, HPD decreased catalase in the hippocampus and striatum. However, the extract prevented this change in the hippocampus. Our results showed that this berry extract has antihyperglycemic and antihyperlipidemic effects, and neuroprotective properties, proving to be a potential therapeutic agent for individuals with metabolic syndrome.


Subject(s)
Anthocyanins/pharmacology , Antioxidants/pharmacology , Glucosides/pharmacology , Hypoglycemic Agents/pharmacology , Hypolipidemic Agents/pharmacology , Metabolic Syndrome/drug therapy , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Psidium/chemistry , Animals , Anthocyanins/chemistry , Antidepressive Agents/chemistry , Antidepressive Agents/pharmacology , Antidepressive Agents/therapeutic use , Antioxidants/chemistry , Behavior, Animal/drug effects , Brazil , Catalase/metabolism , Corpus Striatum/drug effects , Corpus Striatum/metabolism , Diet, Carbohydrate Loading/adverse effects , Disease Models, Animal , Glucose Intolerance/chemically induced , Glucose Intolerance/drug therapy , Glucose Intolerance/metabolism , Glucosides/chemistry , Hippocampus/drug effects , Hippocampus/metabolism , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/chemistry , Hypolipidemic Agents/therapeutic use , Metabolic Syndrome/chemically induced , Metabolic Syndrome/metabolism , Neuroprotective Agents/chemistry , Neuroprotective Agents/therapeutic use , Oxidative Stress/drug effects , Plant Extracts/chemistry , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Tandem Mass Spectrometry , Weight Gain/drug effects
10.
Redox Rep ; 23(1): 41-46, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29088999

ABSTRACT

OBJECTIVE: Insulin resistance (IR) plays an important role in the development of many diseases, such as diabetes mellitus. Therefore, the aim of the present study was to evaluate the effects of the extracts from fruits native to Brazil on metabolic parameters and hepatic oxidative markers in an animal model of insulin resistance induced by dexamethasone (DEX). METHODS: Wistar rats received water or extracts of Eugenia uniflora or Psidium cattleianum, once a day for 21 days. For the last 5 days, the rats received an intraperitoneal injection of saline or DEX. RESULTS: DEX caused a reduction in body weight gain and relative pancreatic weight, as well as glucose intolerance, and an increase in serum glucose and triacylglycerol levels. The extracts were found to prevent hyperglycemia and hypertriglyceridemia. DEX caused an increase in the levels of thiobarbituric acid-reactive substances and reactive oxygen species production in the liver of rats, and both extracts prevented these changes. In addition, hepatic glutathione peroxidase activity was reduced by DEX. However, total thiol content and activities of catalase, superoxide dismutase, and delta-aminolevulinate dehydratase were not altered in any of the tested groups. CONCLUSION: Fruit extracts of E. uniflora and P. cattleianum exhibited considerable antihyperglycemic, antidyslipidemic, and antioxidant effects, and may be useful in the therapeutic management of alterations due to IR.


Subject(s)
Antioxidants/pharmacology , Hypoglycemic Agents/pharmacology , Insulin Resistance , Plant Extracts/pharmacology , Animals , Brazil , Dexamethasone/toxicity , Disease Models, Animal , Dyslipidemias/chemically induced , Dyslipidemias/drug therapy , Enzymes/metabolism , Eugenia/chemistry , Fruit/chemistry , Hypolipidemic Agents/pharmacology , Liver/drug effects , Liver/metabolism , Male , Oxidative Stress/drug effects , Psidium/chemistry , Rats, Wistar
11.
Biomed Pharmacother ; 92: 935-941, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28618655

ABSTRACT

The aim of this study was to investigate the effect of Eugenia uniflora fruit (red type) extract on metabolic status, as well as on neurochemical and behavioral parameters in an animal model of metabolic syndrome induced by a highly palatable diet (HPD). Rats were treated for 150days and divided into 4 experimental groups: standard chow (SC) and water orally, SC and E. uniflora extract (200mg/kg daily, p.o), HPD and water orally, HPD and extract. Our data showed that HPD caused glucose intolerance, increased visceral fat, weight gain, as well as serum glucose, triacylglycerol, total cholesterol and LDL cholesterol; however, E. uniflora prevented these alterations. The extract decreased lipid peroxidation and prevented the reduction of superoxide dismutase and catalase activities in the prefrontal cortex, hippocampus and striatum of animals submitted to HPD. We observed a HPD-induced reduction of thiol content in these cerebral structures. The extract prevented increased acetylcholinesterase activity in the prefrontal cortex caused by HPD and the increase in immobility time observed in the forced swim test. Regarding chemical composition, LC/MS analysis showed the presence of nine anthocyanins as the major compounds. In conclusion, E. uniflora extract showed benefits against metabolic alterations caused by HPD, as well as exhibited antioxidant and antidepressant-like effects.


Subject(s)
Antidepressive Agents/pharmacology , Antioxidants/pharmacology , Brain/drug effects , Depression/prevention & control , Eugenia/chemistry , Fruit/chemistry , Metabolic Syndrome/prevention & control , Plant Extracts/pharmacology , Acetylcholinesterase/metabolism , Adiposity/drug effects , Animals , Antidepressive Agents/isolation & purification , Antidepressive Agents/standards , Antioxidants/isolation & purification , Antioxidants/standards , Behavior, Animal/drug effects , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Brain/metabolism , Brain/physiopathology , Catalase/metabolism , Depression/blood , Depression/physiopathology , Depression/psychology , Diet, High-Fat , Dietary Sucrose , Disease Models, Animal , Dyslipidemias/blood , Dyslipidemias/chemically induced , Dyslipidemias/prevention & control , GPI-Linked Proteins/metabolism , Glucose Intolerance/blood , Glucose Intolerance/chemically induced , Glucose Intolerance/prevention & control , Lipid Peroxidation/drug effects , Lipids/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/physiopathology , Motor Activity/drug effects , Obesity/blood , Obesity/chemically induced , Obesity/prevention & control , Phytotherapy , Plant Extracts/isolation & purification , Plant Extracts/standards , Plants, Medicinal , Rats, Wistar , Superoxide Dismutase/metabolism , Time Factors , Weight Gain/drug effects
12.
Biomed Pharmacother ; 88: 939-947, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28178625

ABSTRACT

The aim of this study was to investigate the effect of blueberry (Vaccinium virgatum) fruit extract on metabolic, behavioral and oxidative stress parameters in the hippocampus and cerebral cortex of mice submitted to an experimental model of metabolic syndrome induced by a highly palatable diet (HPD). Mice C57BL/6 were divided into 4 experimental groups: (1) received standard chow and saline orally, (2) received standard chow and blueberry hydroalcoholic extract, (3) received HPD and saline orally, (4) received HPD and blueberry hydroalcoholic extract. The animals were treated for 150days. Our results showed that the animals fed with HPD presented insulin resistance, increased body weight, visceral fat, glucose, triglycerides, and total cholesterol when compared to the control group. The blueberry extract prevented the increase of these metabolic parameters. Also, the extract was able to reduce the levels of thiobarbituric acid reactive substances in the cerebral cortex and hippocampus of animals submitted to HPD. In contrast, no differences were observed in the total thiol content, activity of the antioxidant enzymes catalase and superoxide dismutase. In addition, the HPD fed animals showed a significant increase in immobility time in the forced swimming test and blueberry prevented this alteration, although no changes were observed in the ambulatory behavior, as well as in the anxiolytic profile of these animals. Overall, our findings suggest that chronic consumption of blueberry extract exhibits hypoglycemic, hypolipidemic, antidepressant-like and antiperoxidative effects in an animal model of metabolic syndrome.


Subject(s)
Adjuvants, Pharmaceutic/therapeutic use , Behavior, Animal/drug effects , Blueberry Plants/chemistry , Fruit/chemistry , Metabolic Syndrome/drug therapy , Metabolic Syndrome/metabolism , Plant Extracts/therapeutic use , Adjuvants, Pharmaceutic/pharmacology , Animals , Anthocyanins/analysis , Anxiety/complications , Anxiety/drug therapy , Catalase/metabolism , Diet , Disease Models, Animal , Glucose Tolerance Test , Hippocampus/drug effects , Hippocampus/pathology , Hippocampus/physiopathology , Male , Maze Learning/drug effects , Metabolic Syndrome/enzymology , Mice, Inbred C57BL , Oxidative Stress/drug effects , Phytochemicals/analysis , Plant Extracts/pharmacology , Sulfhydryl Compounds/metabolism , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
13.
Brain Res Bull ; 127: 260-269, 2016 10.
Article in English | MEDLINE | ID: mdl-27769874

ABSTRACT

The aim of the present study was to evaluate the protective effects of blueberry extract on oxidative stress and inflammatory parameters in a model of mania induced by ketamine administration in rats. Male rats were pretreated with blueberry extract (200mg/kg, once a day for 14days), lithium chloride (45mg/kg, mood stabilizer used as a positive control, twice a day for 14days), or vehicle. Between the 8th and 14th days, rats also received an injection of ketamine (25mg/kg) or vehicle. In the 15th day, thirty minutes after ketamine administration the hyperlocomotion of the animals was assessed in the open - field apparatus. Immediately after the behavioral analysis brain and blood were collected for biochemical determinations. ketamine treatment induced hyperlocomotion and oxidative damage in cerebral cortex, hippocampus and striatum such as an increase in lipid peroxidation and a decrease in the antioxidant enzymes activities (superoxide dismutase, catalase e glutatione peroxidase). Ketamine administration also increased the IL-6 levels in serum in rats. Pretreatment of rats with blueberry extract or lithium prevented the hyperlocomotion, pro - oxidant effects and inflammation induced by ketamine. Our findings suggest that blueberry consumption has a neuroprotective potential against behavioral and biochemical dysfunctions induced in a preclinical model that mimic some aspects of the manic behavior.


Subject(s)
Bipolar Disorder/drug therapy , Blueberry Plants , Phytotherapy , Plant Extracts/pharmacology , Psychotropic Drugs/pharmacology , Animals , Bipolar Disorder/metabolism , Bipolar Disorder/pathology , Brain/drug effects , Brain/metabolism , Brain/pathology , Catalase/metabolism , Disease Models, Animal , Glutathione Peroxidase/metabolism , Interleukin-6/blood , Ketamine , Lithium Compounds/pharmacology , Male , Motor Activity/drug effects , Motor Activity/physiology , Oxidative Stress/drug effects , Oxidative Stress/physiology , Rats, Wistar , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
14.
Neurochem Res ; 40(7): 1421-30, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25998886

ABSTRACT

Cecropia species are widely used in traditional medicine by its anti-diabetic, anti-hypertensive and anti-inflammatory properties. In the present study, we investigated the neuroprotective and antioxidant effects of the crude aqueous extract from Cecropia pachystachya leaves in a rat model of mania induced by ketamine. The results indicated that ketamine treatment (25 mg/kg i.p., for 8 days) induced hyperlocomotion in the open-field test and oxidative damage in prefrontal cortex and hippocampus, evaluated by increased lipid peroxidation, carbonyl protein formation and decreased total thiol content. Moreover, ketamine treatment reduced the activity of the antioxidant enzymes superoxide dismutase and catalase in hippocampus. Pretreatment of rats with C. pachystachya aqueous extract (200 and 400 mg/kg p.o., for 14 days) or with lithium chloride (45 mg/kg p.o., for 14 days, used as a positive control) prevented both behavioral and pro-oxidant effects of ketamine. These findings suggest that C. pachystachya might be a useful tool for preventive intervention in bipolar disorder, reducing the episode relapse and the oxidative damage associated with the manic phase of this disorder .


Subject(s)
Bipolar Disorder/prevention & control , Ketamine/toxicity , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Urticaceae/chemistry , Animals , Behavior, Animal , Chromatography, High Pressure Liquid , Female , Hippocampus/drug effects , Hippocampus/metabolism , Locomotion/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Rats, Wistar
15.
Nat Prod Commun ; 9(7): 941-2, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25230498

ABSTRACT

As a continuation of our research on the Baccharis genus, the evaluation of the antioxidant effect by TRAP and TBARS assays of three isolated compounds from n-butanol fractions of B. articulata and B. usterii is reported. The structures of these compounds were established as 4-O-beta-D-glucopyranosyl-3,5-dimethoxybenzyl-methanol (1), 5-O-[E]-dicaffeoylquinic acid (2), and 7-hydroxy-5,4'-dimethoxyflavone (3). In the TRAP assay it was possible to observe an antioxidant effect of both n-butanol fractions at 1.25 microg/mL. Among the isolated compounds, compound 2 displayed a remarkable contribution to the total antioxidant capacity of the n-butanol fraction of B. usterii. Moreover, the n-butanol fractions of both species, compounds 1 and 2 at 40.0 microg/mL were efficient in protection of lipid peroxidation in the TBARS experiment. They are promising lead compounds for use in medicinal chemistry studies.


Subject(s)
Antioxidants/pharmacology , Baccharis/chemistry , Phenols/chemistry , Phenols/pharmacology , Antioxidants/chemistry , Baccharis/classification , Thiobarbituric Acid Reactive Substances/chemistry
16.
Brain Res Bull ; 108: 10-7, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25108233

ABSTRACT

Chronic stressful stimuli influence disease susceptibility to depression, cardiovascular, metabolic and neurodegenerative disorders. The present work investigated antidepressant and antioxidant properties of the aqueous extract from Cecropia pachystachya in a mouse model of chronic unpredictable stress (CUS). Our results indicated that acute administration of the aqueous extract (AE) from C. pachystachya (200 and 400mg/kg, p.o.) produced an antidepressant-like effect in the forced swimming test (FST). The chronic treatment with C. pachystachya extract (200mg/kg, p.o., for 14 days) prevented the depressant-like effect but not the anxiogenic effect induced by CUS. In addition to the behavioral modifications, the 14 days of CUS increased lipid peroxidation in the hippocampus (HP) and prefrontal cortex (PFC), decreased total thiol content and glutathione peroxidase activity in the HP. C. pachystachya AE administration during CUS protocol was able to prevent the oxidative damage induced by stress. However, no changes were observed in the activity of the antioxidant enzymes superoxide dismutase and catalase in the above cited brain areas after the stress protocol and treatment. Our results suggest that C. pachystachya prevented both depressive behavior and oxidative damage induced by CUS, supporting its neuroprotective potential against behavioral and biochemical dysfunctions induced by chronic stress.


Subject(s)
Antidepressive Agents/pharmacology , Cecropia Plant , Depression/prevention & control , Plant Extracts/pharmacology , Stress, Psychological/prevention & control , Animals , Antidepressive Agents/administration & dosage , Anxiety/prevention & control , Chronic Disease , Disease Models, Animal , Male , Mice , Motor Activity/drug effects , Plant Extracts/administration & dosage
17.
Molecules ; 19(5): 5806-20, 2014 May 06.
Article in English | MEDLINE | ID: mdl-24806580

ABSTRACT

Because of the need for more effective and less harmful antifungal therapies, and interest in the synthesis of new carboximidamides, the goal of this study was to determine the antifungal and anti-enzyme activities of some new pyrazole carboximidamides and their cytotoxicity. For this purpose, tests were performed to evaluate: minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC); production of proteinases and phospholipase, and cytotoxicity of the extracts. Data were analyzed by ANOVA and Tukey Tests (α = 5%). The results were: MIC and MFC ≥ 62.5 µg/mL (C. albicans, C. parapsilosis, C. famata, C. glabrata, and Rhodotorula mucillaginosa) and MIC and MFC ≥ 15.6 µg/mL (C. lipolytica). The values of proteinase and phospholipase (Pz) of C. albicans before and after exposure to the compounds were: 0.6 (±0.024) and 0.2 (±0.022) and 0.9 (±0.074) and 0.3 (±0.04), respectively. These proteinase results were not significant (p = 0.69), but those of phospholipase were (p = 0.01), and 15.6 µg/mL was the most effective concentration. The cytotoxicity means were similar among the tests (p = 0.32). These compounds could be useful as templates for further development through modification or derivatization to design more potent antifungal agents. Data from this study provide evidence that these new pyrazole formulations could be an alternative source for the treatment of fungal infections caused by Candida. However, a specific study on the safety and efficacy of these in vivo and clinical trials is still needed, in order to evaluate the practical relevance of the in vitro results.


Subject(s)
Antifungal Agents/administration & dosage , Candida/drug effects , Mycoses/drug therapy , Pyrazoles/chemical synthesis , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Candida/pathogenicity , Enzyme Inhibitors/therapeutic use , Humans , Microbial Sensitivity Tests , Mycoses/pathology , Pyrazoles/administration & dosage , Pyrazoles/chemistry
18.
J Med Food ; 17(3): 324-31, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24476224

ABSTRACT

The antibiofilm and antibacterial properties against Pseudomonas aeruginosa and Staphylococcus epidermidis and chemical characterization of six hydroethanolic blueberry extracts (blueberry rabbiteye-Vaccinium virgatum) from different cultivars and means of propagation were investigated. The total flavonoid, anthocyanin, and phenolic contents were determined by specific and well-established methods. Among the cultivars, Briteblue showed the lowest content of all metabolites analyzed, while Bluegem showed the highest concentrations of these compounds. All the micropropagated cultivars presented the highest amounts of chlorogenic acid. The blueberry fruit extracts showed strong activity against S. epidermidis biofilm (up to 84% inhibition) without inhibiting bacterial growth. Likewise, Bluegem micropropagated extract, which had the highest anthocyanin, flavonoids, and phenolic compound content, demonstrated the highest S. epidermidis biofilm inhibitory effect. Finally, a linear correlation between the total phenolic content and the percentage of biofilm inhibition was observed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Blueberry Plants/chemistry , Plant Extracts/pharmacology , Pseudomonas aeruginosa/drug effects , Staphylococcus epidermidis/drug effects , Fruit/chemistry , Pseudomonas aeruginosa/physiology , Staphylococcus epidermidis/physiology
19.
Eur J Pharmacol ; 724: 132-9, 2014 Feb 05.
Article in English | MEDLINE | ID: mdl-24384407

ABSTRACT

Bipolar disorder (BD) is a chronic and debilitating illness characterized by recurrent manic and depressive episodes. Our research investigates the protective effects of curcumin, the main curcuminoid of the Indian spice turmeric, in a model of mania induced by ketamine administration in rats. Our results indicated that ketamine treatment (25 mg/kg, for 8 days) induced hyperlocomotion in the open-field test and oxidative damage in prefrontal cortex (PFC) and hippocampus (HP), evaluated by increased lipid peroxidation and decreased total thiol content. Moreover, ketamine treatment reduced the activity of the antioxidant enzymes superoxide dismutase and catalase in the HP. Pretreatment of rats with curcumin (20 and 50 mg/kg, for 14 days) or with lithium chloride (45 mg/kg, positive control) prevented behavioral and pro-oxidant effects induced by ketamine. These findings suggest that curcumin might be a good compound for preventive intervention in BD, reducing the episode relapse and the oxidative damage associated with the manic phase of this disorder.


Subject(s)
Antimanic Agents/therapeutic use , Antioxidants/therapeutic use , Bipolar Disorder/drug therapy , Curcumin/therapeutic use , Neuroprotective Agents/therapeutic use , Animals , Antimanic Agents/pharmacology , Antioxidants/pharmacology , Behavior, Animal/drug effects , Bipolar Disorder/chemically induced , Bipolar Disorder/metabolism , Catalase/metabolism , Curcumin/pharmacology , Female , Hippocampus/drug effects , Hippocampus/metabolism , Ketamine , Motor Activity/drug effects , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
20.
J Pharm Pharmacol ; 66(5): 733-46, 2014 May.
Article in English | MEDLINE | ID: mdl-24372555

ABSTRACT

OBJECTIVES: Eugenol, obtained from clove oil (Eugenia caryophyllata), possess several biological activities. It is anti-inflammatory, analgesic, anaesthesic, antipyretic, antiplatelet, anti-anaphylactic, anticonvulsant, anti-oxidant, antibacterial, antidepressant, antifungal and antiviral. The anti-oxidant activity of eugenol have already been proven. From this perspective testing, a series of planned structural derivatives of eugenol were screened to perform structural optimization and consequent increase of the potency of these biological activities. METHODS: In an attempt to increase structural variability, 16 compounds were synthesized by acylation and alkylation of the phenolic hydroxyl group. Anti-oxidant activity capacity was based on the capture of DPPH radical (2,2-diphenyl-1-picryl-hydrazyl), ABTS radical 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid), measure of TBARS (thiobarbituric acid-reactive species), total sulfhydryl and carbonyl content (eugenol derivatives final concentrations range from 50 to 200 µm). KEY FINDINGS: Four derivatives presented an efficient concentration to decrease 50% of the DPPH radical (EC50 ) < 100 µm, which has a good potential as a free-radical scavenger. Three of these compounds also showed reduction of ABTS radical. Eugenol derivatives presenting alkyl or aryl (alkylic or arylic) groups substituting hydroxyl 1 of eugenol were effective in reducing lipid peroxidation, protein oxidative damage by carbonyl formation and increase total thiol content in cerebral cortex homogenates. In liver, the eugenol derivatives evaluated had no effect. CONCLUSIONS: Our results suggest that these molecules are promising anti-oxidants agents.


Subject(s)
Antioxidants/pharmacology , Eugenol/pharmacology , Lipid Peroxidation/drug effects , Oxidative Stress/drug effects , Plant Extracts/pharmacology , Protein Carbonylation/drug effects , Syzygium/chemistry , Animals , Benzothiazoles/metabolism , Biphenyl Compounds/metabolism , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Eugenol/analogs & derivatives , Liver/drug effects , Male , Picrates/metabolism , Rats, Wistar , Sulfhydryl Compounds/metabolism , Sulfonic Acids/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...